![Stuart L. Dombey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stuart L. Dombey
Founder at QuatRx Pharmaceuticals Co.
Stuart L. Dombey active positions
Companies | Position | Start | End |
---|---|---|---|
QuatRx Pharmaceuticals Co.
![]() QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Chief Tech/Sci/R&D Officer | 2000-11-19 | - |
Founder | 2000-11-19 | - |
Career history of Stuart L. Dombey
Former positions of Stuart L. Dombey
Companies | Position | Start | End |
---|---|---|---|
Squibb Corp. | General Counsel | - | - |
Hoechst UK Ltd. | Corporate Officer/Principal | - | - |
Parke-Davis & Co. Ltd.
![]() Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | General Counsel | 1989-12-31 | - |
Training of Stuart L. Dombey
The University of Liverpool | Graduate Degree |
Statistics
International
United Kingdom | 4 |
United States | 3 |
Operational
General Counsel | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
QuatRx Pharmaceuticals Co.
![]() QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
Parke-Davis & Co. Ltd.
![]() Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Health Technology |
Squibb Corp. | Health Technology |
Hoechst UK Ltd. |
- Stock Market
- Insiders
- Stuart L. Dombey
- Experience